Today
CBA’s Matt Comyn loses his right-hand man, the meticulous David Cohen
Over 15 years at the bank, David Cohen has seen it all. On his retirement, he provides a potted history of CBA’s numerous troubles and its transformation.
- James Eyers
This Month
Advisory roles shift gears at Perpetual, Luminis scores broader role
Street Talk understands Luminis Partners’ role at the $2.9 billion financial services player has widened out to include broader advisory remit.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Bankers strike $5b of M&A deals in Christmas rush
Christmas came early for the country’s investment bankers on Monday after more than $5 billion in deals were struck in one morning, setting up a blockbuster close to what has otherwise been a lacklustre year for transaction activity.
- Aaron Weinman
- Opinion
- Wall Street
The Fed runs a fool’s errand on bank capital rules
Finding a risk model that captures potential embezzlement, consumer abuse and money laundering losses is no easy task.
- Marc Rubinstein
- Opinion
- Chanticleer
Good riddance to Link, an ASX rollercoaster
The company is systemically important to Australia’s superannuation system. But it didn’t always behave that way.
- Anthony Macdonald
Where Perth’s top dealmakers love to lunch
Wining and dining in the Wild West is remarkably different – and cheaper – from the east coast hubs of Melbourne and Sydney.
- Aaron Weinman and Tom Rabe
- Opinion
- Chanticleer
Chemist Warehouse deal just part of David Di Pilla’s big plan
In helping to bring the retail giant and Sigma together, he is playing the long game and hopes to create a “mini Blackstone” in Australia.
- James Thomson
- Opinion
- Chanticleer
Sigma’s 40pc pop: a FOMO story on a Chemist Warehouse scale
Too bad Chemist Warehouse came just as investors are winding down for Christmas. Can the FOMO survive the break?
- Anthony Macdonald
Men’s health player Mosh appoints adviser to explore exit options
Gavin Jacobson’s advisory firm has won the sell-side mandate to explore options for Mosh.
- Sarah Thompson, Kanika Sood and Emma Rapaport
- Opinion
- Chanticleer
Why Chemist Warehouse creates a quandary for fund managers
The structure of Chemist Warehouse’s deal with Sigma means fund managers who like the growth story face tough decisions on when and how to get a slice of the action.
- Updated
- James Thomson
- Opinion
- Chanticleer
Is the backdoor the new way to the ASX boards?
If Chemist Warehouse can do it, what’s stopping Virgin Australia listing via Rex? Or Molycop via Monadelphous? The IPO game has taken an interesting twist.
- Anthony Macdonald
How David Di Pilla dreamt up the Chemist Warehouse deal over sushi
Five months ago, over a sushi dinner at Melbourne’s Nobu, Sigma boss Vikesh Ramsunder and his major shareholder David Di Pilla were toasting a win. Then the lightbulb moment hit.
- Aaron Weinman
The fate of ANZ and Suncorp deal is in the hands of these three people
The high-stakes legal battle over whether the $4.9 billion transaction should proceed is half done. And so far, it is unclear who’s on top.
- James Eyers
Soul Patts leaves door open to more M&A after $3b Perpetual bid
The investment manager, with $900 million in cash, wants to pounce on “undervalued companies” that will fall victim to higher rates and weakened valuations.
- Aaron Weinman
Barrenjoey star banker jumps back to the buy side
Sources said Dean Fremder will join the investment management boutique Firetrail as an equity analyst in the new year.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Project Dawn: A flyer, a banker and a candlestick maker
Ords corporate finance team knows its target better than most, having advised Dusk on its $124 million initial public offering in October 2020.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Barrenjoey banker jumps ship
Kevin Chong was a principal at the local investment bank.
- Sarah Thompson, Kanika Sood and Emma Rapaport
A $23b Canadian investor woos super funds with Ed Sheeran, Madonna
The investor is raising $763 million for the next frontier of private credit – asset-based financings backed by music royalties and legal finance.
- Aaron Weinman
- Opinion
- Chanticleer
Eight-year quest to float Chemist Warehouse ends abruptly
Missing Chemist Warehouse’s IPO would be a career limiting move. But when the whole street misses it, play on.
- Anthony Macdonald
- Updated
- Mergers & acquisitions
Perpetual rejects Soul Patts’ $3b bid
Perpetual has rejected the $3 billion proposal saying it “materially undervalues” the company’s various businesses.
- Updated
- Jonathan Shapiro and Anthony Macdonald
